Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln
13/05/2026 06:37
May 13 (Reuters) - Sprint Bioscience AB SPRINT.ST: Q1 NET SALES AMOUNT TO 0 MSEK Q1 OPERATING RESULT AT -14.3 MSEK Source text: ID:nMFN8QjjXm Further company coverage: SPRINT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln
Brief: Sprint Bioscience Completes Strategic Evaluation Of STK25 Program
Brief: Sprint Bioscience Appoints Jenni Björnulfson As CFO
Brief: Sprint Bioscience Reports Positive Proof-Of-Concept Results From Program In CKD
Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program